Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial

Trial Profile

Delayed Start to Ovarian Stimulation Improves Oocyte Maturation and Quality: A Randomized Trial

Discontinued
Phase of Trial: Phase III

Latest Information Update: 22 Jul 2014

At a glance

  • Drugs Ganirelix (Primary)
  • Indications Female infertility
  • Focus Therapeutic Use
  • Acronyms DOS/DOR
  • Most Recent Events

    • 10 Jun 2014 According to the ClinicalTrials.gov record, status changed from recruiting to discontinued.
    • 03 Jun 2013 Planned end date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
    • 13 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top